28 related articles for article (PubMed ID: 33823338)
21. PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Mao C; Yang ZY; Hu XF; Chen Q; Tang JL
Ann Oncol; 2012 Jun; 23(6):1518-25. PubMed ID: 22039088
[TBL] [Abstract][Full Text] [Related]
22. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
[TBL] [Abstract][Full Text] [Related]
23. Histological growth patterns and molecular analysis of resected colorectal lung metastases.
Pilozzi E; Fedele D; Montori A; Lorenzon L; Peritore V; Mannocchi G; Bagheri N; Leone C; Palumbo A; Roberto M; Ranazzi G; Rendina E; Balducci G; Ibrahim M
Pathol Res Pract; 2021 Jun; 222():153414. PubMed ID: 33823338
[TBL] [Abstract][Full Text] [Related]
24. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Therkildsen C; Bergmann TK; Henrichsen-Schnack T; Ladelund S; Nilbert M
Acta Oncol; 2014 Jul; 53(7):852-64. PubMed ID: 24666267
[TBL] [Abstract][Full Text] [Related]
25. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.
Passiglia F; Bronte G; Bazan V; Galvano A; Vincenzi B; Russo A
Crit Rev Oncol Hematol; 2016 Mar; 99():150-7. PubMed ID: 26775732
[TBL] [Abstract][Full Text] [Related]
26. Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.
Feng QY; Wei Y; Chen JW; Chang WJ; Ye LC; Zhu DX; Xu JM
World J Gastroenterol; 2014 Apr; 20(15):4263-75. PubMed ID: 24764664
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
28. Impact of somatic mutations on patterns of metastasis in colorectal cancer.
Lipsyc M; Yaeger R
J Gastrointest Oncol; 2015 Dec; 6(6):645-9. PubMed ID: 26697197
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
